Advertisements


Citi starts Sirius with Neutral rating, $15 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 11th, 2019

Goldman starts DocuSign with Neutral rating, $45 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

Citi starts Dicerna with Buy rating, $27 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Citi starts Rigel Pharmaceuticals with Buy rating, $8.50 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 27th, 2018

Huya stock falls after Goldman Sachs starts coverage with neutral rating

Shares of Chinese game-streaming company Huya Inc. are down 1% in Friday morning trading after Goldman Sachs analyst Piyush Mubayi initiated coverage of the stock with a neutral rating and $34 price target. "We believe the .....»»

Category: topSource: marketwatchAug 3rd, 2018

Citi starts Cision with a Buy rating, $21 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 2nd, 2018

Citi starts Instructure with a Buy rating, $55 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 16th, 2018

Jefferies starts Kala Pharmaceuticals with Buy rating, $15 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytMar 14th, 2019

Mizuho starts Atlassian with Buy rating, $120 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 14th, 2019

Mizuho starts ServiceNow with Buy rating, $265 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 14th, 2019

Why Goldman Sachs Is More Bullish on Carnival

Carnival Corp. (NYSE: CCL) was featured in Wednesday’s top analyst upgrades and downgrades as Goldman Sachs raised its rating on the shares to Buy from Neutral. While the $65 price target was........»»

Category: blogSource: 247wallstMar 13th, 2019

Ladenburg starts Rhythm Pharmaceuticals with Buy rating, $43 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 13th, 2019

Cantor starts Crinetics with Overweight rating, $40 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 12th, 2019

Jefferies starts TCR2 Therapeutics with Buy rating, $31 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 11th, 2019

The Worst Might Be Over for High-Yielding CenturyLink Stock --- for Now

MoffettNathanson dropped its price target to $12 from $16 but raised its rating to Neutral from Sell, reflecting the company‚Äôs cloudy future......»»

Category: topSource: barronsFeb 20th, 2019

B. Riley FBR starts G1 Therapeutics with Buy rating, $55 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 7th, 2019

Jefferies starts Visa with Buy rating, $170 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 28th, 2019

JPMorgan starts Tencent Music with Overweight rating, $16 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 17th, 2019

86 Research starts NIO Inc. with a Sell rating, $4.70 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 15th, 2019

Citi Slashes Roku Price Target, Names 5 Reasons For Staying Neutral

After losing around half of its entire market capitalization since peaking in mid-2017 at $77.57, Roku Inc (NASDAQ: ROKU) should not be bought by investors, according to Citi. Latest Ratings for ROKU .....»»

Category: blogSource: benzingaJan 14th, 2019

Buckingham starts Hovnanian at Neutral with 90c price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 11th, 2019